Final results from M72 AS01E TB Vaccine Trial
The final results from the M72AS01E TB vaccine study have been published in the New England Journal of Medicine. The vaccine demonstrated a 50% efficacy rate in the incidence of lung TB disease in HIV-negative adults, already infected with latent...
Community Engagement
Carina's Choice: SATVI collaborated with UCT Drama Department and Worcester Secondary School in developing this play which was performed by learners from Worcester Secondary School at 8 local high schools reaching approximately 8 000 adolescents in...
Phase 3 efficacy study finds shortened 4-month TB drug therapy treatment equivalent to 6-months therapy
The New England Journal of Medicine has published the results of a clinical study which shows that in a randomised phase 3 clinical trial, a shortened 4-month TB treatment was equivalent to the standard 6-month TB treatment.
2020 Annual Report
The SATVI 2020 Annual Report is available for download.
New multi-functional TB blood test validated
Researchers the South African Tuberculosis Vaccine Initiative (SATVI), the Center for Global Infectious Disease Research(USA) and a large consortium of collaborators have developed a validated a new, simple blood-based test that has the potential to...


Sunday, 28 November 2021
Vacancy Postdoctoral Fellowship: Single Cell Immunology

We are inviting applications for a postdoctoral fellowship in single cell immunology. The successful candidate will perform single cell RNA sequencing and mass cytometry assays on samples collected postmortem from humans as part of a multi-center study. Closing date 30 November 2021. 

Publication Date:
Thu, 28 Oct 2021 - 10:45
20 September 2021 New Upload: 20 year SATVI Corporate History

The corporate history of the South African Tuberculosis Vaccine Initiative is available online. This history is the result of more than 20 interviews conducted over a period of about one year with SATVI staff and students, including many colleagues who have left, but are very much still part of the SATVI TB research family.

Publication Date:
Wed, 22 Sep 2021 - 21:45
31 August 2021UCT’s Dr Virginie Rozot awarded Wellcome Leap grant for TB research

SATVI's research officer Dr Virginie Rozot, has been awarded a multi‑year contract from the Wellcome Leap’s Delta Tissue (∆T) programme to study human immune system’s response to the tuberculosis (TB) bacterium, in the human thoracic lymph nodes.

Publication Date:
Wed, 01 Sep 2021 - 09:00
6 July 2021 Radiological and functional evidence of the bronchial spread of tuberculosis: an observational analysis

SATVI researchers have published a journal article titled: "Radiological and functional evidence of the bronchial spread of tuberculosis: an observational analysis" appearing in the Lancet Microbe journal.

Publication Date:
Thu, 15 Jul 2021 - 12:45